Sector valuations Dr. Lal PathLabs Limited
Stocks
LALPATHLAB
INE600L01024
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,732.70 INR | +0.55% |
|
+4.79% | +16.87% |
| 06-17 | Dr. Lal PathLabs' Volume Boom Comes at a Cost | |
| 05-04 | Nomura Adjusts Dr. Lal PathLabs' Price Target to INR1,860 From INR1,800, Keeps at Buy | MT |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 48.91x | 10.18x | 3.08x | 8.7x | 30.91x | 38.57x | 1.06% | 2.99B | ||
| -166.49x | 21.25x | -17.33x | 13.84x | -188.68x | -152.34x | -.--% | 39.72B | ||
| 18.74x | 2.37x | 0.48x | 1.83x | 10.54x | 12.44x | 1.07% | 22.3B | ||
| 17.22x | 1.22x | 1.02x | 1.34x | 7.62x | 13.92x | 5.05% | 7.43B | ||
| 314.92x | - | -1.77x | - | - | - | - | 4.83B | ||
| -19.77x | - | -0.06x | - | - | - | - | 1.96B | ||
| -32.53x | - | 0.69x | - | - | - | -.--% | 1.89B | ||
| 36.33x | 1.87x | -0.12x | 1.72x | 13.65x | 22.6x | 1.4% | 1.92B | ||
| 32.2x | 1.89x | 0.04x | 1.15x | 9.61x | 14.02x | 0.78% | 1.85B | ||
| 12.98x | 1.73x | 0.96x | 1.34x | 5.26x | 8.98x | 5.83% | 1.77B | ||
| 83.45x | 14.99x | 4.25x | 17.38x | 42.92x | 58.52x | 0.12% | 1.49B | ||
| 59.22x | 8.16x | 1.59x | 7.09x | 29.26x | 42.3x | 0.35% | 1.23B | ||
| 32.82x | 1.38x | -2.13x | 0.8x | 6.68x | 22.84x | 3.7% | 1.15B | ||
| -3.96x | 0.52x | -3.97x | 0.96x | - | -2.44x | - | 906M | ||
| 43x | 13.23x | 2.1x | - | - | - | 2.03% | 878M | ||
| 18.24x | 1.05x | -14.33x | - | - | - | 3.41% | 847M | ||
| 26.95x | 2.02x | 1.05x | - | - | - | 0.36% | 830M | ||
| -46.68x | - | 1.56x | 198.75x | -43.35x | -41.16x | - | 651M | ||
| Average | 26.42x | 5.85x | -1.27x | 21.24x | -6.87x | 3.19x | 1.8% | 5.26B | |
| Weighted average by Cap. | -43.03x | 11.67x | -7.11x | 9.59x | -84.59x | -63.95x | 1.03% |
- Stock Market
- Stocks
- LALPATHLAB Stock
- Sector Dr. Lal PathLabs Limited
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















